Fatal case of HIV and COVID-19

Elhadi M, Momen AA, Ali Senussi Abdulhadi OM, Msherghi A.

Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS

Mahmood K, Rashed ER, Oliveros E, Chau VQ, Hermle T, Jacobs S, Lala A, Singhvi A, Parikh A, Pinney SP.

HIV and shifting epicenters for COVID-19, an alert for some countries

Doungmo Goufo EF, Khan Y, Chaudhry QA.

Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City

Miyashita H, Kuno T.

Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: A cross-sectional survey

Siewe Fodjo JN, Faria de Moura Villela E, Van Hees S, Tibério Dos Santos T, Vanholder P, Vanholder P, Reyntiens P, Van den Bergh R, Colebunders R.

The Burden of Anxiety During the COVID-19 Pandemic Among People Living with HIV (PLHIV) in Pune, India

Marbaniang I, Sangle S, Nimkar S, Zarekar K, Salvi S, Chavan A, Gupta A, Suryavanshi N, Mave V.

The Diagnostic Trap Occurred in Two COVID-19 Cases Combined Pneumocystis Pneumonia in Patient with AIDS

Guo W, Wang M, Ming F, Tang W, Liang K.

A rapid qualitative assessment of the impact of the COVID-19 pandemic on a racially/ethnically diverse sample of gay, bisexual, and other men who have sex with men living with HIV in the US South

Rhodes SD, Mann-Jackson L, Alonzo J, Garcia M, Tanner AE, Smart BD, Horridge DN, Dam CNV, Wilkin AM.

Driving Force of Covid-19 Among People Living With HIV/AIDS in Wuhan, China

Guo W, Ming F, Dong Y, Zhang Q, Liu L, Gao M, Zhang X, Mo P, Feng Y, Tang W, Liang K.

The Psychosocial Effects of the COVID-19 Pandemic on Youth Living with HIV in Western Kenya

Dyer J, Wilson K, Badia J, Agot K, Neary J, Njuguna I, Kibugi J, Healy E, Beima-Sofie K, John-Stewart G, Kohler P.

Case Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2

Rivas N, Espinoza M, Loban A, Luque O, Jurado J, Henry-Hurtado N, Goodridge A.

The COVID-19 Ibuprofen controversy; a systematic review of NSAIDs in adult acute lower respiratory tract infections

Vaja R, Chan J, Ferreira P, Harky A, Rogers LJ, Gashaw HH, Kirkby NS, Mitchell JA.

The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV

Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ.

Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study

Huang J, Xie N, Hu X, Yan H, Ding J, Liu P, Ma H, Ruan L, Li G, He N, Wei S, Wang X.

Characteristics and outcomes of COVID-19 in patients with HIV: a multi-center research network study

Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR.

Factors associated with hospital admission for COVID-19 in HIV patients

Di Biagio A, Ricci E, Calza L, Squillace N, Menzaghi B, Rusconi S, Orofino G, Bargiacchi O, Molteni C, Valsecchi L, Cenderello G, Ferrara S, Saracino A, Maggi P, Falasca K, Taramasso L, Bonfanti P; CISAI Study group.

Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening

Bartilotti-Matos F, Davies P.

How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis

An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report

Tian C, Tang L, Wu J, Li W, Ming X, Zhou H, Wu W, Zeng X.

Author Correction: COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy

Patel RH, Acharya A, Mohan M, Byrareddy SN.

COVID-19 related anxiety in people living with HIV: An online cross-sectional study

Kuman TunÇel Ö, PullukÇu H, Erdem HA, Kurtaran B, TaŞbakan SE, TaŞbakan M.

Editor's comment

Saag M.

HIV infection and COVID-19: risk factors for severe disease

Etienne N, Karmochkine M, Slama L, Pavie J, Batisse D, Usubillaga R, Letembet VA, Brazille P, Canouï E, Slama D, Joumaa H, Canoui-Poitrine F, Segaux L, Weiss L, Viard JP, Salmon D; COVID-19 ID Team.

Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study

Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, Martinez-Rebollar M, Laguno M, Callau P, Gonzalez-Navarro A, Leal L, Garcia F, Mallolas J, Mosquera M, Marcos MA, Ambrosioni J, Miro JM, Martinez E, Blanco JL; (on behalf the COVID-19 in HIV Investigators).

Antiretrovirals and risk of COVID-19 diagnosis and hospitalization in HIV-positive persons

Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA; Spanish HIV/COVID-19 Collaboration.

Modelling the impact of COVID-19 on HIV

Lesosky M, Myer L.

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models

Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, Martin-Hughes R, Teng Y, Glaubius R, Mahiane SG, Bansi-Matharu L, Taramusi I, Chagoma N, Morrison M, Doherty M, Marsh K, Bershteyn A, Hallett TB, Kelly SL; HIV Modelling Consortium.

PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa

Golin R, Godfrey C, Firth J, Lee L, Minior T, Phelps BR, Raizes EG, Ake JA, Siberry GK.

Control of epidemics by jails: lessons for COVID-19 from HIV

Ohuabunwa T, Spaulding AC.

PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa

Davey DLJ, Bekker LG, Mashele N, Gorbach P, Coates TJ, Myer L.

How COVID-19 could benefit tuberculosis and HIV services in South Africa

Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, Triviño-Duran L.

COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19

Velez JCQ, Caza T, Larsen CP.

COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy

Calza L, Bon I, Tadolini M, Borderi M, Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P, Viale P, Attard L.

Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa

Abah RC.

COVID-19 Vulnerability of Transgender Women With and Without HIV Infection in the Eastern and Southern U.S

Poteat TC, Reisner SL, Miller M, Wirtz AL.

Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infections

Hammoud MA, Maher L, Holt M, Degenhardt L, Jin J, Murphy D, Bavinton B, Grulich A, Lea T, Haire B, Bourne A, Saxton P, Vaccher S, Ellard J, Mackie B, Batrouney C, Bath N, Prestage G.

Six Lessons for COVID-19 Rehabilitation From HIV Rehabilitation

Brown DA, O'Brien KK, Josh J, Nixon SA, Hanass-Hancock J, Galantino M, Myezwa H, Fillipas S, Bergin C, Baxter L, Binette M, Chetty V, Cobbing S, Corbett C, Ibanez-Carrasco F, Kietrys D, Roos R, Solomon P, Harding R.

Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior

Torres TS, Hoagland B, Bezerra DRB, Garner A, Jalil EM, Coelho LE, Benedetti M, Pimenta C, Grinsztejn B, Veloso VG.

In the shadow of COVID-19: HIV-infected individuals need more attention

Zhao T, Xuan K, Uy JP, Sun C.

COVID-19 Among People Living with HIV: A Systematic Review

Mirzaei H, McFarland W, Karamouzian M, Sharifi H.

Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes

Winston A, De Francesco D, Post F, Boffito M, Vera J, Williams I, Anderson J, Mallon PWG, Sabin CA; POPPY Study Group.

COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic

Weiss SH, Wormser GP.

The Impact of COVID-19 on Older Adults Living with HIV: HIV Care and Psychosocial Effects

Brown MJ, Weissman SB.

Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City

Suwanwongse K, Shabarek N.

Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study

Jeong HE, Lee H, Shin HJ, Choe YJ, Filion KB, Shin JY.

Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies

Kala S, Dunk C, Acosta S, Serghides L.

Mistakes from the HIV pandemic should inform the COVID-19 response for maternal and newborn care

Gribble K, Mathisen R, Ververs MT, Coutsoudis A.

Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?

Barrera-López P, Pérez-Riveros ED, Moreno-Montoya J, Ballesteros SM, Valencia SA, De la Hoz-Valle JA.

SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort

Maggiolo F, Zoboli F, Arosio M, Valenti D, Guarneri D, Sangiorgio L, Ripamonti D, Callegaro A.

Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention

Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, Westergaard RP.

Changing the Use of HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men During the COVID-19 Pandemic in Melbourne, Australia

Chow EPF, Hocking JS, Ong JJ, Schmidt T, Buchanan A, Rodriguez E, Maddaford K, Patel P, Fairley CK.

COVID-19 affects HIV and tuberculosis care

Abdool Karim Q, Abdool Karim SS.

Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4(+) T cell count

Menghua W, Xin Z, Jianwei L, Yu Z, Qinwei Y.

Preserving two decades of healthcare gains for africa in the Covid-19 era

Pastakia SD, Braitstein P, Gal√°rraga O, Genberg B, Said J, Vedanthan R, Wachira J, Hogan JW.

Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China

Guo W, Ming F, Feng Y, Zhang Q, Mo P, Liu L, Gao M, Tang W, Liang K.

HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns

Lesko CR, Bengtson AM.

COVID-19 attack rate in HIV-infected patients and in PrEP users

Charre C, Icard V, Pradat P, Brochier C, Lina B, Chidiac C, Cotte L.

HIV/SARS-CoV-2 coinfection: a global perspective

Kanwugu ON, Adadi P.

What HIV in the brain can teach us about SARS-CoV-2 neurologic complications?

Al-Harthi L, Campbell EM, Schneider JA, Bennett DA.

HIV postexposure prophylaxis during the COVID-19 pandemic: experience from Madrid

Sánchez-Rubio J, Vélez-Díaz-Pallarés M, Rodríguez González C, Sanmartin Fenollera P, García Yubero C, Fernández-Pacheco García-Valdecasas M.

Descriptive Analysis of Patients Living with HIV Affected By COVID-19

Gudipati S, Brar I, Murray S, McKinnon JE, Yared N, Markowitz N.

Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA

Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, Ofotokun I, Sheth AN.

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, Hamlet A, Smith JA, Winskill P, Verity R, Baguelin M, Lees JA, Whittles LK, Ainslie KEC, Bhatt S, Boonyasiri A, Brazeau NF, Cattarino L, Cooper LV, Coupland H, Cuomo-Dannenburg G, Dighe A, Djaafara BA, Donnelly CA, Eaton JW, van Elsland SL, FitzJohn RG, Fu H, Gaythorpe KAM, Green W, Haw DJ, Hayes S, Hinsley W, Imai N, Laydon DJ, Mangal TD, Mellan TA, Mishra S, Nedjati-Gilani G, Parag KV, Thompson HA, Unwin HJT, Vollmer MAC,

HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?

Sands P.

Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD

Fauci A, Inserro A.

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

Cooper TJ, Woodward BL, Alom S, Harky A.

Lessons from HIV to Guide COVID-19 Responses in the Central African Republic

Somse P, Eba PM.

Clinical characteristics in patients with SARS-CoV-2/HBV co-infection

Chen L, Huang S, Yang J, Cheng X, Shang Z, Lu H, Cheng J.

Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine

Rozanova J, Shenoi S, Zaviryukha I, Zeziulin O, Kiriazova T, Rich K, Mamedova E, Yariy V.

Conducting rapid qualitative research to support sex workers' health and social needs in the face of COVID-19: capitalising on stakeholder networks from the HIV response in Singapore to drive policymaking

Tan RKJ, Lim JM, Lo JJ, Teo AKJ, O'Hara CA, Ching AH, Ho V, Wong ML.

SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States

Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R.

Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Ferreira LMR, Mostajo-Radji MA.

[Research progress of the impact of COVID-19 outbreak on people living with HIV]

Chen FF, Tang HL, Lyu P.

Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men

Santos GM, Ackerman B, Rao A, Wallach S, Ayala G, Lamontage E, Garner A, Holloway IW, Arreola S, Silenzio V, Strömdahl S, Yu L, Strong C, Adamson T, Yakusik A, Doan TT, Huang P, Cerasuolo D, Bishop A, Noori T, Pharris A, Aung M, Dara M, Chung SY, Hanley M, Baral S, Beyrer C, Howell S.

Prevalence of COVID-19-like symptoms among people living with HIV, and using antiretroviral therapy for prevention and treatment

SeyedAlinaghi S, Ghadimi M, Hajiabdolbaghi M, Rasoolinejad M, Abbasian L, Nezhad MH, Manshadi SD, Ghadimi F, Ahmadinejad Z.

HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa

Davies MA.

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cumhur Cure M, Kucuk A, Cure E.

COVID-19 and HIV co-infection an emerging consensus

Masukume G, Mapanga W, Grinberg S, van Zyl DS.

HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India

Marimuthu J, Kumar BS, Aravind Gandhi P.

Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine; from HIV-1 infection to COVID-19

Naghipour S, Ghodousi M, Rahsepar S, Elyasi S.

Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

Ancy I, Sivanandam M, Kumaradhas P.

When COVID-19 Crosses Paths with AIDS in the Homeless

Przydzial P, Tchomobe G, Amin K, Christian E, Okoh AK.

Learning from People with HIV: Their Insights are Critical to Our Response to the Intersecting COVID-19 and HIV Pandemics in Africa

Aristide C, Okello S, Bwana M, Siedner MJ, Peck RN.

Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV

Meyerowitz EA, Kim AY, Ard KL, Basgoz N, Chu JT, Hurtado RM, Lee CK, He W, Minukas T, Nelson S, Ojikutu BO, Robbins G, Sanchez S, Triant VA, Zachary K, Gandhi RT.

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study

Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA.

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Smolders EJ, Te Brake LH, Burger DM.

Applying the Popular Opinion Leader Intervention for HIV to COVID-19

Quinn KG.

Attendance to HIV Antiretroviral Collection Clinic Appointments During COVID-19 Lockdown. A Single Center Study in Kigali, Rwanda

Pierre G, Uwineza A, Dzinamarira T.

Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China

Ruan L, Zhang Y, Luo Y, Yu X, Zeng Y, Peng H, Han L, Chen L, Roy S, Cheng Q, Li H, Guo X, Xiong D, Gan H, Liu M.

„Wir vermuten einen Schutzfaktor!“ : COVID-19 trifft HIV-Patienten meist nur leicht

Springer Medizin.

HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa

Cainelli F, Dzudzor B, Lanzafame M, Goushchi A, Chhem S, Vento S.

Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series

Hu Y, Ma J, Huang H, Vermund SH.

Outcomes among HIV-positive patients hospitalized with COVID-19

Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, Reich J, Jones S, Rahimian J.

NO SIGNIFICANT EFFECT OF COVID-19 ON IMMUNOLOGICAL AND VIROLOGICAL PARAMETERS IN PATIENTS WITH HIV-1 INFECTION

Calza L, Bon I, Borderi M, Colangeli V, Viale P.

Alarm at the Gate-Health and Social Inequalities are Comorbid Conditions of HIV and COVID-19

Harris OO, Leblanc N, McGee K, Randolph S, Wharton MJ, Relf M.

Antiretroviral HIV drugs in COVID-19 research: promises and risks. An opinion piece

Waters L, Rockstroh JK.

COVID-19 in 3 people living with HIV in the United Kingdom

Toombs JM, Van den Abbeele K, Democratis J, Merricks R, Mandal AKJ, Missouris CG.

Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection

Patel RH.

Using social media and technology to communicate in pediatric HIV research: A qualitative study with young adults born with or exposed at birth to HIV

Berman CA, Kacanek D, Nichamin M, Wilson D, Davtyan M, Salomon L, Patel K, Reznick M, Tassiopoulos K, Lee S, Bauermeister J, Paul M, Aldape T, Seage Iii G.

Structural Biology Aids the Research of New Anti-COVID-19 Drugs

Lu J, Liu X.

Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia

Kalichman SC, Eaton LA, Berman M, Kalichman MO, Katner H, Sam SS, Caliendo AM.

Personal historical perspective of HIV: part 11

Welsby PD.

Addressing Health Inequities Exacerbated by COVID-19 Among Youth With HIV: Expanding Our Toolkit

Armbruster M, Fields EL, Campbell N, Griffith DC, Kouoh AM, Knott-Grasso MA, Arrington-Sanders R, Agwu AL.

Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China

Li W, Ma Q, Wang X, Tang M, Lin J, Xiao B.

The COVID-19 response must integrate people living with HIV needs in Sub-Saharan Africa: the case of Mali

Sagaon-Teyssier L, Yattassaye A, Bourrelly M, Dembélé Keïta B, Spire B.

Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2

Gao A, Chen Z, Segal FP, Carrington M, Streeck H, Chakraborty AK, Julg B.

All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus

Ding X, Yin K, Li Z, Liu C.

Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil

Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, Grinsztejn B.

Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics

Dauby N.

How to Have Sex in an Epidemic Redux: Reinforcing HIV Prevention in the COVID-19 Pandemic

Newman PA, Guta A.

NSAIDs for analgesia in the era of COVID-19

Herzberg DL, Sukumaran HP, Viscusi E.

Home Birth in the Era of COVID-19: Counseling and Preparation for Pregnant Persons Living with HIV

Premkumar A, Cassimatis I, Berhie SH, Jao J, Cohn SE, Sutton SH, Condron B, Levesque J, Garcia PM, Miller ES, Yee LM.

Living with HIV in the time of COVID-19: a glimpse of hope

Adadi P, Kanwugu ON.

Laser Safety Measures for The Treatment of Genital Warts in Hiv+ Patients During The Covid-19 Pandemic

Cameli N, Mariano M, Latini A, Morrone A, Cristaudo A.

Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation

Müller H, Kniepeiss D, Stauber R, Schrem H, Rauter M, Krause R, Schemmer P.

A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan

Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Yamamoto K, Ohmagari N.

Impact of the COVID-19 Pandemic on HIV Testing and Assisted Partner Notification Services, Western Kenya

Lagat H, Sharma M, Kariithi E, Otieno G, Katz D, Masyuko S, Mugambi M, Wamuti B, Weiner B, Farquhar C.

COVID-19 Lockdowns: Impact on Facility-Based HIV Testing and the Case for the Scaling Up of Home-Based Testing Services in Sub-Saharan Africa

Mhango M, Chitungo I, Dzinamarira T.

In the shadow of HIV & TB: A commentary on the COVID epidemic in South Africa

Bulled N, Singer M.

COVID-19 pneumonia in patients with HIV - A Case Series

Okoh AK, Bishburg E, Grinberg S, Nagarakanti S.

The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Dursun R, Temiz SA.

COVID-19 in people with HIV

Xu Z, Zhang C, Wang FS.

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL; COVID-19 ID Team.

Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19

Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, Sobieszczyk ME.

A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois

Ridgway JP, Farley B, Benoit JL, Frohne C, Hazra A, Pettit N, Pho M, Pursell K, Saltzman J, Schmitt J, Uvin AZ, Pitrak D, McNulty M.

HIV postexposure prophylaxis during COVID-19

Junejo M, Girometti N, McOwan A, Whitlock G; Dean Street Collaborative Group.

Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City

Suwanwongse K, Shabarek N.

Adapting Substance Use Treatment for HIV Affected Communities During COVID-19: Comparisons Between a Sexually Transmitted Infections (STI) Clinic and a Local Community Based Organization

Rogers BG, Arnold T, Schierberl Scherr A, Strong SH, Holcomb R, Daley Ndoye C, Pinkston M, Chan PA.

Hospitalized patients with COVID-19 and HIV: a case series

Childs K, Post FA, Norcross C, Ottaway Z, Hamlyn E, Quinn K, Juniper T, Taylor C.

The effects of COVID-19 on the health and socio-economic security of sex workers in Nairobi, Kenya: Emerging intersections with HIV

Kimani J, Adhiambo J, Kasiba R, Mwangi P, Were V, Mathenge J, Macharia P, Cholette F, Moore S, Shaw S, Becker M, Musyoki H, Bhattacharjee P, Moses S, Fowke KR, McKinnon LR, Lorway R.

Concealment of Potential Exposure to COVID-19 and Its Impact on Outbreak Control: Lessons from the HIV Response

Teo AKJ, Tan RKJ, Prem K.

COVID-19 in an HIV-positive Kidney Transplant Recipient

Kumar RN, Tanna SD, Shetty AA, Stosor V.

"Everything is a Mess": How COVID-19 is Impacting Engagement with HIV Testing Services in Rural Southwestern Uganda

Ponticiello M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, King R, Sundararajan R.

Reimagining the Future of HIV Service Implementation in the Philippines Based on Lessons from COVID-19

Quilantang MIN, Bermudez ANC, Operario D.

Covid-19 and Gender in LMICs: Potential Lessons from HIV Pandemic

Small E, Sharma BB, Nikolova SP.

COVID-19 and Hidden Housing Vulnerabilities: Implications for Health Equity, New Haven, Connecticut

Rosenberg A, Keene DE, Schlesinger P, Groves AK, Blankenship KM.

COVID-19 in a patient with HIV infection

Patel RH, Pella PM.

Adapting to the COVID-19 Pandemic: Continuing HIV Prevention Services for Adolescents Through Telemonitoring, Brazil

Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, Grangeiro A; Brazilian PrEP1519 Study Group.

Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism

Jaiswal J, LoSchiavo C, Perlman DC.

Clinical Care, Research, and Telehealth Services in the Era of Social Distancing to Mitigate COVID-19

Young SD, Schneider J.

COVID-19, Telemedicine, and Patient Empowerment in HIV Care and Research

Mgbako O, Miller EH, Santoro AF, Remien RH, Shalev N, Olender S, Gordon P, Sobieszczyk ME.

HIV and SARS-CoV-2 co-infection: A case report from Uganda

Baluku JB, Mwebaza S, Ingabire G, Nsereko C, Muwanga M.

The impact of COVID-19 on HIV financing in Nigeria: a call for proactive measures

Oladele TT, Olakunde BO, Oladele EA, Ogbuoji O, Yamey G.

Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E)

Parang K, El-Sayed NS, Kazeminy AJ, Tiwari RK.

Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient

Haddad S, Tayyar R, Risch L, Churchill G, Fares E, Choe M, Montemuro P.

What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?

Amimo F, Lambert B, Magit A.

COVID-19 in patients with HIV.

Jones R, Nelson M, Bracchi M, Asboe D, Boffito M.

COVID-19 in patients with HIV - Authors' reply.

Miró JM, Ambrosioni J, Blanco JL.

FAKE SCIENCE: XMRV, COVID-19 AND THE TOXIC LEGACY OF DR JUDY MIKOVITS.

Neil S, Campbell EM.

HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe?

COVID-19 Comes 40 Years After AIDS - Any Lesson?

Soriano V, Barreiro P, Ramos JM, Eirós JM, de Mendoza C.

Clinical features and outcomes of HIV patients with coronavirus disease 2019.

Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, Atzori C, Ridolfo A, Cattaneo D.

COVID-19, HIV, and Migrant Workers: The Double Burden of the Two Viruses.

Lodge W 2nd, Kuchukhidze S.

Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?

Laurence J.

A case of HIV and SARS-CoV-2 co-infection in Singapore.

Recovery from COVID-19 in two patients with coexisted HIV infection.

Wu Q, Chen T, Zhang H.

Confronting Another Pandemic: Lessons from HIV can Inform Our COVID-19 Response.

Edelman EJ, Aoun-Barakat L, Villanueva M, Friedland G.

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.

Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, Müller M, Römer K, Schewe K, Hoffmann C.

Keep It Going if You Can": HIV Service Provision for Priority Populations During the COVID-19 Pandemic in Seattle, WA.

Beima-Sofie K, Ortblad KF, Swanson F, Graham SM, Stekler JD, Simoni JM.

HIV and Food Insecurity: A Syndemic Amid the COVID-19 Pandemic.

McLinden T, Stover S, Hogg RS.

Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China.

Sun S, Hou J, Chen Y, Lu Y, Brown L, Operario D.

HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic, Chicago, IL.

Ridgway JP, Schmitt J, Friedman E, Taylor M, Devlin S, McNulty M, Pitrak D.

The time is now: expedited HIV differentiated service delivery during the COVID-19 pandemic.

The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.

Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, Kousoulas KG.

A personal historical perspective of HIV.

Welsby PD.

Covid-19-The real role of NSAIDs in Italy.

de Girolamo L, Peretti GM, Maffulli N, Brini AT.

Lessons learned from HIV can inform our approach to COVID-19 stigma.

Assessing HIV-Related Stigma in Healthcare Settings in the Era of the COVID-19 Pandemic, Pittsburgh, Pennsylvania.

Krier S, Bozich C, Pompa R, Friedman MR.

Routine Screening for HIV in an Urban Emergency Department During the COVID-19 Pandemic.

Stanford KA, Friedman EE, Schmitt J, Spiegel T, Ridgway JP, Moore M, Taylor M, Pitrak D, McNulty MC.

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?

A COVID-19 conference at AIDS 2020: Virtual.

COVID-19 and Antiretroviral Therapies: South Africa's Charge Towards 90-90-90 in the Midst of a Second Pandemic.

Mendelsohn AS, Ritchwood T.

Prioritizing Community Partners and Community HIV Workers in the COVID-19 Pandemic.

Operario D, King EJ, Gamarel KE.

Considerations for STI Clinics during the COVID-19 pandemic.

Napoleon SC, Maynard MA, Almonte A, Cormier K, Bertrand T, Ard KL, Chan PA.

Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020.

Sanchez TH, Zlotorzynska M, Rai M, Baral SD.

Development of Telemedicine Infrastructure at an LGBTQ+‚ÄâClinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI.

Rogers BG, Coats CS, Adams E, Murphy M, Stewart C, Arnold T, Chan PA, Nunn A.

HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.

Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K.

COVID-19: Increased Risk to the Mental Health and Safety of Women Living with HIV in South Africa.

Joska JA, Andersen L, Rabie S, Marais A, Ndwandwa ES, Wilson P, King A, Sikkema KJ.

Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.

Peavy KM, Darnton J, Grekin P, Russo M, Green CJB, Merrill JO, Fotinos C, Woolworth S, Soth S, Tsui JI.

COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers.

Pinto RM, Park S.

The Virus that Changed Spain: Impact of COVID-19 on People with HIV.

Ballester-Arnal R, Gil-Llario MD.

Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US.

Nosyk B, Armstrong WS, Del Rio C.

COVID-19 Policies can Perpetuate Violence Against Transgender Communities: Insights from Peru.

Perez-Brumer A, Silva-Santisteban A.

Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count.

Wang M, Luo L, Bu H, Xia H.

The Impact of COVID-19 on Syringe Services Programs in the United States.

Glick SN, Prohaska SM, LaKosky PA, Juarez AM, Corcorran MA, Des Jarlais DC.

From HIV to Coronavirus: AIDS Service Organizations Adaptative Responses to COVID-19, Birmingham, Alabama.

Kay ES, Musgrove K.

COVID-19-Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa.

Nyoni T, Okumu M.

Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic.

Eaton LA, Kalichman SC.

Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV.

Marziali ME, Card KG, McLinden T, Wang L, Trigg J, Hogg RS.

Darunavir does not prevent SARS-CoV-2 infection in HIV patients.

Riva A, Conti F, Bernacchia D, Pezzati L, Sollima S, Merli S, Siano M, Lupo A, Rusconi S, Cattaneo D, Gervasoni C.

Raids on Immigrant Communities During the Pandemic Threaten the Country's Public Health.

Lopez MM, Holmes SM.

SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV.

Drain PK, Garrett N.

Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome.

Su J, Shen X, Ni Q, Zhao H, Cai J, Zhu B, Wu W, Lang G, Xu K, Sheng J.

Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions.

Hightow-Weidman L, Muessig K, Claude K, Roberts J, Zlotorzynska M, Sanchez T.

Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report.

Peng Z, Wang J, Mo Y, Duan W, Xiang G, Yi M, Bao L, Shi Y.

COVID-19 in patients with HIV: clinical case series.

Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, Miro JM; COVID-19 in HIV Investigators..

The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.

Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN.

Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic.

Saberi P.

Symptoms, Stress, and HIV-Related Care Among Older People Living with HIV During the COVID-19 Pandemic, Miami, Florida.

Algarin AB, Varas-Rodríguez E, Valdivia C, Fennie KP, Larkey L, Hu N, Ibañez GE.

Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19.

Shoptaw S, Goodman-Meza D, Landovitz RJ.

Understanding the Impact of COVID-19 on Latino Sexual Minority Men in a US HIV Hot Spot.

Harkness A, Behar-Zusman V, Safren SA.

Demographic science aids in understanding the spread and fatality rates of COVID-19.

Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y, Mills MC.

Three lessons for the COVID-19 response from pandemic HIV.

Hargreaves J, Davey C; Group for lessons from pandemic HIV prevention for the COVID-19 response..

Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.

Mascolo S, Romanelli A, Carleo MA, Esposito V.

Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).

Chen J, Cheng X, Wang R, Zeng X.

Contracting HIV or Contracting SAR-CoV-2 (COVID- 19) in Pregnancy? Balancing the Risks and Benefits.

Joseph Davey D, Bekker LG, Coates TJ, Myer L.

What's Old is New! Similarities Between SARS-CoV-2 and HIV.

Relf MV.

Tuberculosis and HIV responses threatened by COVID-19.

Adepoju P.

Tested by HIV and TB, South Africa confronts new pandemic.

Maintaining HIV care during the COVID-19 pandemic.

Jiang H, Zhou Y, Tang W.

Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV.

Zhao J, Liao X, Wang H, Wei L, Xing M, Liu L, Zhang Z.

Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.

Zhu F, Cao Y, Xu S, Zhou M.

How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research.

Logie CH, Turan JM.

Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19.

Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S, Pallikkuth S, Hirshfield S.

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

Russell B, Moss C, Rigg A, Van Hemelrijck M.

Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases.

Torjesen I.

The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health.

Alpalh√£o M, Filipe P.

EMA advice on the use of NSAIDs for Covid-19.

[No authors listed]

Editorial: Managing the march of COVID-19: lessons from the HIV and AIDS epidemic.

Whiteside A, Parker W, Schramm M.

[Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV].

Guo W, Weng HL, Bai H, Liu J, Wei XN, Zhou K, Sande A.

SARS-CoV-2 and HIV.

Joob B, Wiwanitkit V.

Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.

Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y.

Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.

Zhu F, Cao Y, Xu S, Zhou M.

HIV-1 did not contribute to the 2019-nCoV genome.

Xiao C, Li X, Liu S, Sang Y, Gao SJ, Gao F.